Planned Departure Of FDA Principal Deputy Commissioner Could Leave Leadership Vacuum

Namandje Bumpus' departure means there is no obvious, internal candidate to serve as acting commissioner when President-elect Donald Trump takes office in January and the Senate works to confirm a new leader.